Production of nitric oxide (NO) in human hydatidosis: Relationship between nitrite production and interferon-γ levels

Biochimie

Volumn 80, Issue 8-9, 1998, Pages 739-744

  Touil Boukoffa, Chafia ^b   Bauvois, Brigitte ^a   Sancéau, Josiane ^a   Hamrioui, Boussad ^b   Wietzerbin, Juana ^a  

^a INSTITUT CURIE   (France)

^b NONE

Author keywords

Hydatidosis; Interferon gamma; Nitric oxide

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 6; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ECHINOCOCCOSIS; ENZYME INDUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREACTIVITY; LUNG CYST; LUNG HYDATID CYST; MAJOR CLINICAL STUDY; MALE;

ECHINOCOCCUS GRANULOSUS;

EID: 0032131512     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(99)80027-3     Document Type: Article

References (19)

1. [1] Moncada S., Higgs E.A., The L arginine-nitric-oxide pathways, N. Engl. J. Med. 329 (1993) 2002-2012.
2. [2] Vouldoukis I., Mazier D., Debré P., Mossalayi M.D., Nitric oxide and human infectious diseases, Res. Immunol. 146 (1995) 689-692.
3. [3] Drapier J.C., Monoxyde d'azote et macrophages, Pathol. Biol. 45 (1997) 110-114.
4. [4] Arock M., Bécherel P.A., Dugas B., Debré P., Mossalayi M.D., Involvement of Fce RII/CD23 and L-arginine dependent pathways in IgE mediated activation of human eosinophils, Biochem. Biophys. Res. Commun. 203 (1994) 265-271.
5. [5] Kolb J.P., Paul-Eugène N., Damais C., Yamaoka K., Drapier J.C., Dugas B., Interleukin-4 stimulates cGMP production by IFN-(activated human monocytes. Involvement of the nitric oxide synthase pathway, J. Biol. Chem. 269 (1994) 9811-9816.
6. [6] Dugas B., Debré P., Moncada S., Nitric oxide, a vital poison inside the immune response and inflammatory network, Res. Immunol. 146 (1995) 664-670.
7. [7] Mannick J.B., Assano K., Isumi K., Kieff E., Stamler J.S., Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein virus reactivation, Cell 79 (1994) 1137-1146.
8. [8] Ouaaz F., Sola B., Issaly F., Kolb J.P., Davi F., Menz F., Arock M., Paul-Eugene N., Korner F., Dugas B., Debré P., Mossalayi M.D., Growth arrest and terminal differentiation of Leukemic myelomonocytic cells induced through the ligation of CD23 antigen, Blood 84 (1994) 3095-3014.
9. [9] Denis M., Tumor necrosis factor and granulocyte macrophage colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: Killing effector mechanisms depends on the generation of reactive nitrogen intermediates, J. Leuk. Biol. 49 (1991) 380-387.
10. [10] Munoz-Fernandez M.A., Fernandez M.A., Fresno M., Activation of human macrophages for the killing of intracellular by Trypanosoma cruzi by TNF-α and IFN-γ through a nitric oxide-dependent mechanism, Immunol. Lett. 33 (1992) 35-40.
11. [11] Nussler A.K., Eling W., Kremner P.G., Patients with Plasmodium falciparum and Plasmodium vivax malaria show increased nitrite and nitrate plasma levels, J. Infect. Dis. 169 (1994) 1418-1419.
12. [12] Cesbron J.Y., Capron M., Capron A., Le diagnostic immunologique de l'hydatidose humaine, Gastroenterol. Clin. Biol 10 (1986) 415-418.
13. [13] Touil-Boukoffa C., Sancéau J., Tayebi B., Wietzerbin J., Relationship among circulating interferon, tumor necrosis factor-α, and interleukin-6 and serologic reaction against parasitic antigen in human hydatidosis, J. Interferon Cytokine Res. 17 (1997) 211-217.
14. [14] Cristol S.P., Toreille J., Mesure du NO et système biologique, Sci. Med. 317 (1994) 549-555.
15. [15] Wietzerbin J., Kolb J.P., Senik A., Der Stepani L., Andrew G., Falcoff R., Studies of purification of human gamma interferon: chromatographic behavior of accompanying IL-2 and B-cell helper activity, J. Interferon Res 4 (1984) 141-151.
16. [16] Sugarman B., Aggarwal B., Hars P.E., Figari I.S., Palladino M.A., Shepard M.S., Recombinant tumor necrosis factor effect on proliferation of normal and transformed cells in vitro. Science 230 (1985) 943-945.
17. [17] Van Snick J., Cayphas S., Vink A., Uttenhove C., Coulie P.G., Simpson R.J., Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B cell hybridoma, Proc. Natl. Acad. Sci. USA 256 (1986) 471-477.
18. [18] Antsey N.M., Weinberg J.B., Hassanaly M.Y., Mwaikambo E.D., Mayenga D., Misukonis M.A., Arnelle D.R., Hollis D., McDonald M.I., Granger D.L., Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type-2 expression, J. Exp. Med. 184 (1996) 557-567.
19. [19] Barres P.J., Nitric oxide and asthma, Res. Immunol. 146 (1995) 698-702.